Phase 3 Readout
IGMS: Phase 3 Topline: SBRT Combined With PD-1 Monoclonal Antibody in Unresectable Colorectal Liver Metastases: A Prospecti
January 20, 2027 · pd-1. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- January 20, 2027
- Company
- IGM Biosciences, Inc. (IGMS)
- Drug
- pd-1
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Phase 3 Readout~month
Phase 3 Topline: SBRT Combined With PD-1 Monoclonal Antibody in Unresectable Colorectal Liver Metastases: A Prospecti
- Company
- IGM Biosciences, Inc. (IGMS)
- Drug
- pd-1
- Indication
- Colorectal Cancer; Liver Metastases